Literature DB >> 17383084

The rise of ablative technologies for treating the small renal mass.

Thomas J Polascik, Vladimir Mouraviev.   

Abstract

Mesh：

Year:  2007        PMID： 17383084     DOI： 10.1016/j.eururo.2007.03.005

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

Review 1.  Focal cryotherapy for prostate cancer.

Authors:  Matvey Tsivian; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

2.  Prospects in percutaneous ablative targeting: comparison of a computer-assisted navigation system and the AcuBot Robotic System.

Authors:  Richard Pollock; Pierre Mozer; Thomas J Guzzo; Jonathan Marx; Brian Matlaga; Doru Petrisor; Bogdan Vigaru; Shadie Badaan; Dan Stoianovici; Mohamad E Allaf
Journal:  J Endourol       Date:  2010-08       Impact factor: 2.942

3.  Recent advances in focal therapy of prostate and kidney cancer.

Authors:  Matvey Tsivian; Thomas J Polascik
Journal:  F1000 Med Rep       Date:  2010-01-18

Review 4.  Management and outcomes of tumor recurrence after focal ablation renal therapy.

Authors:  Alberto Breda; Christine Anterasian; Arie Belldegrun
Journal:  J Endourol       Date:  2010-05       Impact factor: 2.619

5.  Percutaneous radiofrequency ablation of renal tumors: a single-center experience.

Authors:  Stephan Seklehner; Hermann Fellner; Paul F Engelhardt; Christoph Schabauer; Claus Riedl
Journal:  Korean J Urol       Date:  2013-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.